SSY Group Limited (LJUIF)
OTC Markets OTCPK · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$0.40255 (+0.00%) as of
Key statistics
- Market cap
- 1.16B
- P/E (TTM)
- 13.42
- EPS (TTM)
- 0.0300
- 52-week range
- 0.4026 – 0.6987
- Beta
- 0.48
- Revenue (TTM)
- 4.38B
- Profit margin
- 11.59%
- Volume
- 700.00
About SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; research, development of biotechnology and related roducts; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. SSY Group Limited was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Wan Chai, Hong Kong
- Employees
- 5,400
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.